NDC 55289-525

ERY-TAB

Erythromycin

ERY-TAB is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, In. The primary component is Erythromycin.

Product ID55289-525_7bbfa7e6-fd37-4750-e053-2991aa0a0d1a
NDC55289-525
Product TypeHuman Prescription Drug
Proprietary NameERY-TAB
Generic NameErythromycin
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2011-04-18
Marketing CategoryANDA / ANDA
Application NumberANDA062298
Labeler NamePD-Rx Pharmaceuticals, In
Substance NameERYTHROMYCIN
Active Ingredient Strength333 mg/1
Pharm ClassesDecreased Sebac
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55289-525-21

21 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-21)
Marketing Start Date2011-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55289-525-63 [55289052563]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-01

NDC 55289-525-30 [55289052530]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-01

NDC 55289-525-42 [55289052542]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-01

NDC 55289-525-40 [55289052540]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-01

NDC 55289-525-21 [55289052521]

ERY-TAB TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062298
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-07-01

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN333 mg/1

Pharmacological Class

  • Decreased Sebaceous Gland Activity [PE]
  • Macrolide [EPC]
  • Macrolide Antimicrobial [EPC]
  • Macrolides [CS]

NDC Crossover Matching brand name "ERY-TAB" or generic name "Erythromycin"

NDCBrand NameGeneric Name
21695-457ERY-TABerythromycin
24338-122ERY-TABErythromycin
24338-124ERY-TABErythromycin
68151-1170ERY-TABERY-TAB
68151-1174ERY-TABERY-TAB
24338-126ERY-TABERY-TAB
43063-569ERY-TABERY-TAB
50090-0339ERY-TABERY-TAB
55289-217ERY-TABERY-TAB
55289-525ERY-TABERY-TAB
0378-8075ERYGELerythromycin
0093-5571ErythromycinErythromycin
0093-5572ErythromycinErythromycin
0168-0215Erythromycinerythromycin
0168-0216Erythromycinerythromycin
0378-8212Erythromycinerythromycin
0404-7191ErythromycinErythromycin
0574-4024erythromycinerythromycin
13668-586ERYTHROMYCINERYTHROMYCIN
13668-588ERYTHROMYCINERYTHROMYCIN
13668-606ErythromycinErythromycin
13668-607ErythromycinErythromycin
13985-605ErythromycinErythromycin
17478-070ErythromycinErythromycin
17478-824ErythromycinErythromycin
21695-173ErythromycinErythromycin
24208-910ErythromycinErythromycin
24338-102ErythromycinErythromycin
24338-104ErythromycinErythromycin
24338-120ERYTHROMYCINErythromycin
21695-387ERYTHROMYCIN Base FilmtabERYTHROMYCIN
21695-389ERYTHROMYCIN Base FilmtabERYTHROMYCIN

Trademark Results [ERY-TAB]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ERY-TAB
ERY-TAB
73286993 1211217 Live/Registered
Abbott Laboratories
1980-11-21
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.